Trial Profile
TRIVERAM-PRACTICE: an open, multi-center, single-arm, non-interventional, observational study in hypertensive outpatients with concomitant primary hypercholesterolemia or mixed hyperlipidemia treated with Triveram in Germany
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2022
Price :
$35
*
At a glance
- Drugs Amlodipine/atorvastatin/perindopril (Primary)
- Indications Dyslipidaemias; Hypertension
- Focus Therapeutic Use
- Acronyms TRIVERAM-PRACTICE
- Sponsors Servier Deutschland
- 01 Jun 2017 Status changed from active, no longer recruiting to completed.
- 19 Jul 2016 New trial record